OptimizeRx has introduced a new programmatic connection point between its proprietary electronic health record (EHR) network and demand-side platforms (DSPs), enabling life sciences marketers to activate authenticated point-of-care advertising campaigns directly through existing programmatic workflows. The launch is designed to simplify access to EHR advertising while expanding OptimizeRx’s reach into the broader programmatic advertising market, which represents nearly 90% of total U.S. digital display ad spending across industries.
The new offering aims to bridge a longstanding gap within healthcare advertising, where life sciences companies have traditionally faced a choice between highly targeted EHR campaigns managed through specialized programs or broader programmatic advertising with limited access to real clinical decision-making environments.
Through the integration of its EHR platform with DSPs, OptimizeRx is now enabling media buyers to leverage the speed, agility, and scale of programmatic advertising along with healthcare professional engagement through authenticated targeting. Marketers can thereby reach healthcare professionals directly in the context of their clinical work flow while retaining more control over campaign management and omnichannel coordination.
Also Read: Kaltura Launches AI Avatar Video Studio for Enterprises
Bringing Programmatic Efficiency to Point-of-Care Advertising
With the addition of the new platform, media buyers can execute campaigns leveraging EHRs much faster using their choice of DSPs without having to control their reach, frequency, and scalability individually. Additionally, the integration is also beneficial for marketers in the healthcare industry who want to integrate EHRs within their omnichannel strategy without using any disjointed processes.
With the increasing adoption of data and personalization in healthcare marketing, the value of authenticated clinical engagement channels continues to rise for pharma companies and life sciences firms.
“The EHR is one of the most impactful places to engage HCPs, but not every life sciences brand has a practical way to access it,” said Steve Silvestro, Chief Executive Officer at OptimizeRx. “This launch changes that picture. Not only does it expand access to key clinical moments, but it also represents a step-change for DSPs seeking a competitive advantage in the life sciences market, opening the door to new demand, stronger client relationships, and higher industry revenues.”
Expanding Opportunities for DSPs in Healthcare Advertising
The launch also creates new opportunities for DSPs looking to strengthen their presence within the growing pharmaceutical digital advertising market. Through direct integration with OptimizeRx’s EHR publisher network, DSPs can now offer life sciences clients authenticated, bot-free healthcare inventory within their native buying environments.
This capability enables DSPs to differentiate themselves with premium point-of-care advertising inventory that has historically been difficult to access at scale. The integration also positions DSPs to capture a larger share of the more than $19 billion pharmaceutical digital advertising market by addressing increasing demand for verified healthcare engagement channels.
Unlike traditional digital advertising environments, authenticated EHR inventory provides marketers with direct access to healthcare professionals during critical treatment and prescribing moments. This level of contextual relevance can improve campaign effectiveness while supporting more meaningful interactions between life sciences brands and healthcare providers.
Strengthening the Future of Healthcare Media Activation
The healthcare advertising landscape is rapidly evolving as pharmaceutical marketers seek more measurable, compliant and targeted engagement strategies. Programmatic advertising has become central to modern media buying, but access to clinically relevant and verified healthcare environments has remained limited for many advertisers.
The latest offering from OptimizeRx is indicative of the larger trend toward convergence between the fields of health technology and programmatic marketing. Through its ability to provide scalable EHR advertising within the context of the DSP platform, it allows companies in the life sciences sector to streamline their media operations while gaining better access to clinically validated targeting.
With the continued growth of need for secure, authenticated health advertising, innovations in programmatic advertising and point-of-care targeting will only become more significant in the years to come.
Comments are closed.